It specifically increases the methylation level of METTL3-dependent hypoxia-inducible factor 2α (HIF-2α), promotes the translation of HIF-2α mRNA, and increases the protein level of HIF-2α, thus promoting the glycolysis of tumor cells and tumor progression [217]. The gene discussed is EPAS1; the disease is neoplasm.